Guide — Labs & Diagnostics
Cardiac & Pulmonary Biomarkers: BNP, Troponin, and D-dimer
The acutely dyspneic patient may have a cardiac cause, a pulmonary cause, or both. BNP, troponin, and D-dimer — read with the chest film and the exam — help point the workup toward the heart or the lungs.
9 min read · Labs & Diagnostics
Written by Apex Respiratory Editorial Team
Educational use only. This material supports respiratory therapy education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional protocols, or physician orders. Always follow facility policies and current provider orders, and verify calculations independently before clinical use.
Overview
A patient who walks into the emergency department short of breath is a diagnostic puzzle. The cause may be cardiac — decompensated heart failure or myocardial ischemia — or it may be pulmonary, such as a COPD exacerbation, pneumonia, or a pulmonary embolism. Frequently it is both at once. None of these conditions announces itself cleanly at the bedside: crackles, hypoxemia, and breathlessness overlap across all of them.
Three blood biomarkers — BNP (or NT-proBNP), troponin, and D-dimer — help narrow that puzzle. Read on their own they can mislead, but read together with the chest film, the exam, the ABG, and imaging, they point toward the organ that is driving the symptoms. This guide walks through what each marker measures, how to interpret it, and what the respiratory therapist does with the result.
Key Concepts
Each biomarker answers a different question. BNP asks whether the ventricle is being stretched. Troponin asks whether heart muscle has been injured. D-dimer asks whether clot is turning over somewhere in the body. None of them is a stand-alone diagnosis — their power comes from combining the pattern with the clinical picture.
| Biomarker | What it measures | Interpretation | Confounders |
|---|---|---|---|
| BNP / NT-proBNP | Ventricular wall stretch (heart failure) | BNP <100 pg/mL makes acute HF unlikely; >400 pg/mL supports it; 100-400 is indeterminate. NT-proBNP uses higher, age-stratified cutoffs. | Age, renal dysfunction, right-heart strain; blunted in obesity |
| Troponin (I or T) | Myocardial injury | Rises in MI but also in demand ischemia, sepsis, renal failure, myocarditis, and PE with RV strain. High-sensitivity assays use the 99th-percentile upper reference limit and serial (delta) values. | Renal failure, sepsis, PE, myocarditis |
| D-dimer | Fibrin breakdown (clot turnover) | Sensitive but not specific for VTE. A negative result with low/intermediate pretest probability rules out PE/DVT without imaging. Age-adjusted cutoff (age x 10 microg/L if >50) improves specificity. | Infection, surgery, trauma, malignancy, pregnancy, age |
BNP and NT-proBNP — the heart-failure marker
B-type natriuretic peptide is released by stretched ventricular myocardium, so it rises when the heart is overloaded and failing. A BNP below about 100 pg/mL makes acute heart failure unlikely and pushes the workup back toward the lungs; a value above about 400 pg/mL supports heart failure. The 100–400 pg/mL range is indeterminate and must be read alongside everything else at the bedside. NT-proBNP, a related peptide, uses higher, age-stratified cutoffs rather than the same numbers.
The caveats matter. BNP rises with age and with renal dysfunction, and it climbs with right-heart strain from cor pulmonale or a large PE — so an elevated value is not automatically left-sided heart failure. In obese patients the response can be blunted, lowering the measured level for a given degree of failure. Even so, BNP remains the single most useful bedside discriminator of a cardiac versus a pulmonary cause of dyspnea.
Troponin — the myocardial-injury marker
Cardiac troponin (I or T) is the marker of myocardial injury. It rises in acute myocardial infarction, but it is not specific to coronary occlusion: it also climbs with demand ischemia, sepsis, renal failure, myocarditis, and pulmonary embolism that strains the right ventricle. In that last case an elevated troponin is not a heart attack — it flags a higher-risk PE with right-ventricular involvement.
High-sensitivity assays interpret troponin against the 99th-percentile upper reference limit and rely on serial, or delta, values rather than a single number. A rising or falling trend across timed draws separates acute injury from a chronically elevated baseline, which is common in patients with renal disease.
D-dimer — the rule-out test for VTE
D-dimer is a fibrin degradation product, elevated whenever clot is forming and breaking down. It is highly sensitive but poorly specific for venous thromboembolism, which means its real value is in ruling PE and DVT out rather than ruling them in. A negative D-dimer in a patient with low or intermediate pretest probability — for example a low or moderate Wells score — effectively excludes venous thromboembolism without imaging.
An age-adjusted cutoff (age × 10 microg/L for patients over 50) improves specificity in older patients and lets more of them avoid scans. Because D-dimer is also raised by infection, surgery, trauma, malignancy, pregnancy, and advanced age, a positive result is non-diagnostic: it simply prompts imaging, typically CT pulmonary angiography. In a patient with a high pretest probability the test adds nothing — go straight to imaging.
What the RT does with the pattern
The respiratory therapist uses the biomarker pattern to anticipate where the patient is headed and to keep the respiratory plan aligned with the likely diagnosis.
- High BNP: points toward diuresis and the cardiac team. Expect management aimed at fluid removal and afterload, and anticipate noninvasive support for pulmonary edema.
- Normal BNP with hypoxemia and clear cardiac markers: points back to the lungs. The breathlessness is more likely a pulmonary problem, so keep the workup focused on COPD, pneumonia, or PE.
- Elevated troponin with a confirmed PE: flags a higher-risk patient with right-ventricular strain who may need closer monitoring and a higher level of care.
In every case, integrate the labs with oxygenation, the ABG, and imaging. The biomarkers narrow the differential; the bedside assessment tells you how the patient is tolerating it right now.
Common Pitfalls
- Treating a high D-dimer as diagnostic of PE. It is a rule-out test; a positive value is non-diagnostic and only prompts imaging.
- Forgetting that PE itself can raise troponin and BNP. Right-heart strain from a large clot lifts both markers without any primary cardiac disease.
- Ignoring renal failure and age as confounders. Both can elevate BNP and troponin independently of an acute event, inflating the numbers.
- Using D-dimer in a high-pretest-probability patient. When suspicion is already high, skip the D-dimer and go straight to imaging.
Board Exam Pearls
- BNP <100 pg/mL makes heart failure unlikely; >400 pg/mL supports it. The 100–400 range is indeterminate.
- D-dimer is a sensitive rule-out, not a diagnosis. A negative result with low/intermediate pretest probability excludes VTE without imaging.
- Use the age-adjusted D-dimer cutoff (age × 10 microg/L if >50). It improves specificity in older patients.
- Troponin rises in PE with right-ventricular strain. An elevated troponin there marks a higher-risk PE, not a coronary event.
FAQ
How does BNP help separate cardiac from pulmonary dyspnea?
B-type natriuretic peptide is released by stretched ventricular myocardium, so it climbs when the heart is failing. A BNP below about 100 pg/mL makes acute heart failure unlikely and steers you back toward a pulmonary cause such as COPD, pneumonia, or PE; a value above about 400 pg/mL supports heart failure. The 100-400 range is indeterminate and has to be read alongside the chest film, the exam, and the rest of the picture. It is the single most useful bedside discriminator of a cardiac versus a pulmonary cause of breathlessness.
Why is a high D-dimer not enough to diagnose a PE?
D-dimer is a fibrin degradation product that rises whenever clot is forming and breaking down anywhere in the body. It is highly sensitive but poorly specific, so it goes up with infection, surgery, trauma, malignancy, pregnancy, and advanced age as well as with venous thromboembolism. A positive D-dimer is therefore non-diagnostic — its real value is as a rule-out test, and a positive result simply prompts imaging such as CT pulmonary angiography.
Can a pulmonary embolism raise troponin?
Yes. A large PE that strains the right ventricle can leak cardiac troponin even though there is no coronary occlusion. In that setting an elevated troponin is not evidence of a heart attack — it marks a higher-risk PE with right-ventricular involvement, and those patients may need closer monitoring. The same PE can also raise BNP through right-heart strain, which is why both markers must be read in context rather than in isolation.
What is the age-adjusted D-dimer cutoff?
For patients older than 50 with a low or intermediate pretest probability, the conventional D-dimer threshold is replaced by an age-adjusted cutoff of age x 10 microg/L. This raises the bar for what counts as a positive result in older patients, improves specificity, and safely lets more of them avoid imaging without missing clinically important venous thromboembolism.
Go deeper
See how each test points toward the heart or the lungs.
Compare the cardiac vs pulmonary workup →Related Resources
Sources
- Kacmarek RM, Stoller JK, Heuer AJ. Egan's Fundamentals of Respiratory Care. 12th ed. Elsevier; 2021. Cardiovascular assessment and monitoring.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.
- Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167.